Rhythm Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Rhythm Pharmaceuticals, Inc.

Jun-25	Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025 RYTM GlobeNewswire
May-14	Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program RYTM GlobeNewswire
May-07	Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update RYTM GlobeNewswire
May-06	Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences RYTM GlobeNewswire